Reduced expression of SOCS5 is found in chronic obstructive pulmonary disease, while in pulmonary hypertension, the downregulation of SOCS5 has led to abnormal proliferation and contraction of pulmonary muscle cells [79,80]. This evidence concerns the gene SOCS5 and pulmonary arterial hypertension.